Treatment of Leg Telangiectasias With Nd:YAG 1064nm
1 other identifier
interventional
30
1 country
1
Brief Summary
Studying the results of treatment of dilated vessels of the lower limbs with laser, and compare them to those obtained with sclerotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 29, 2010
CompletedFirst Posted
Study publicly available on registry
May 6, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedMay 6, 2010
August 1, 2009
7 months
April 29, 2010
May 5, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
treatment of leg telangiectasias
Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.
first day
Treatment of telangiectasias
Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.
1 month
Secondary Outcomes (2)
Presence of adverse effects
after 1 month
Pain Scores on the Visual Analog Scale
After 1 month
Study Arms (2)
Laser Nd:YAG 1064nm
EXPERIMENTALPatients with leg telangiectasias are treated with 3 sessions of Nd:YAG 1064nm, with 14 days interval
Sclerotherapy
ACTIVE COMPARATORPatients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval
Interventions
Patients with leg telangiectasias are treated with 3 sessions of Nd:YAG 1064nm, with 14 days interval
Patients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval
Eligibility Criteria
You may qualify if:
- Patients with leg telangiectasias
You may not qualify if:
- Arterial disease
- Varices
- Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital das Clinicas da FMUSP
São Paulo, São Paulo, 04534000, Brazil
Related Publications (4)
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983 Apr 29;220(4596):524-7. doi: 10.1126/science.6836297.
PMID: 6836297BACKGROUNDColes CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Lasers Surg Med. 2002;30(2):154-9. doi: 10.1002/lsm.10028.
PMID: 11870796BACKGROUNDBaumler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006 Aug;155(2):364-71. doi: 10.1111/j.1365-2133.2006.07314.x.
PMID: 16882176BACKGROUNDDudelzak J, Hussain M, Goldberg DJ. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009 Mar;8(3):227-9.
PMID: 19271368BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nelson Wolosker, MD, PhD
Hospital das Clinicas, University of Sao Paulo
- PRINCIPAL INVESTIGATOR
Marco Munia, MD
Hospital das Clinicas, University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 29, 2010
First Posted
May 6, 2010
Study Start
August 1, 2009
Primary Completion
March 1, 2010
Study Completion
July 1, 2010
Last Updated
May 6, 2010
Record last verified: 2009-08